Free Access
Med Sci (Paris)
Volume 32, Number 2, Février 2016
Page(s) 198 - 203
Section M/S Revues
Published online 02 March 2016
  1. Pellestor F. Âge maternel et anomalies chromosomiques dans les ovocytes humains. Med Sci (Paris) 2004 ; 20 : 691–696. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Jones KT Mammalian egg activation: from Ca2+ spiking to cell cycle progression. Reproduction 2005 ; 130 : 813–823. [CrossRef] [PubMed] [Google Scholar]
  3. Krauchunas AR, Wolfner MF. Molecular changes during egg activation. Curr Top Dev Biol 2013 ; 102 : 267–292. [CrossRef] [PubMed] [Google Scholar]
  4. Amdani SN, Yeste M, Jones C, Coward K. Sperm factors and oocyte activation: current controversies and considerations. Biol Reprod 2015 ; 93 : 50. [CrossRef] [PubMed] [Google Scholar]
  5. Saunders CM, Larman MG, Parrington J, et al. PLC zeta: a sperm-specific trigger of Ca2+ oscillations in eggs and embryo development. Development 2002 ; 129 : 3533–3544. [PubMed] [Google Scholar]
  6. Yoon SY, Eum JH, Lee JE, et al. Recombinant human phospholipase C zeta 1 induces intracellular calcium oscillations and oocyte activation in mouse and human oocytes. Hum Reprod 2012 ; 27 : 1768–1780. [CrossRef] [PubMed] [Google Scholar]
  7. Kouchi Z, Fukami K, Shikano T, et al. Recombinant phospholipase C zeta has high Ca2+ sensitivity and induces Ca2+oscillations in mouse eggs. J Biol Chem 2004 ; 279 : 10408–10412. [CrossRef] [PubMed] [Google Scholar]
  8. Viaud J, Payrastre B. Les phosphoinositides : ces lipides qui coordonnent la dynamique cellulaire. Med Sci (Paris) 2015 ; 31 : 996–1005. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. Hajnóczky G, Thomas AP. Minimal requirements for calcium oscillations driven by the IP3 receptor. EMBO J 1997 ; 16 : 3533–3543. [CrossRef] [PubMed] [Google Scholar]
  10. Yoon SY, Jellerette T, Salicioni AM, et al. Human sperm devoid of PLC Zeta1 fail to induce Ca2+ release and are unable to initiate the first step of embryo development. J Clin Invest 2008 ; 118 : 3671–3681. [CrossRef] [PubMed] [Google Scholar]
  11. Kashir J, Konstantinidis M, Jones C, et al. A maternally inherited autosomal point mutation in human phospholipase C zeta (PLCζ) leads to male infertility. Hum Reprod 2012 ; 27 : 222–231. [CrossRef] [PubMed] [Google Scholar]
  12. Yoon HJ, Kim HJ, Bae IH, et al. An effective method for improving outcomes in patients with a fertilization defect. Clin Exp Reprod Med 2014 ; 41 : 137–139. [CrossRef] [PubMed] [Google Scholar]
  13. Aarabi M, Balakier H, Bashar S, et al. Sperm-derived WW domain-binding protein, PAWP, elicits calcium oscillations and oocyte activation in humans and mice. FASEB J 2014 ; 28 : 4434–4440. [CrossRef] [PubMed] [Google Scholar]
  14. Wu AT, Sutovsky P, Manandhar G, et al. PAWP, a sperm-specific WW domain-binding protein, promotes meiotic resumption and pronuclear development during fertilization. J Biol Chem 2007 ; 282 : 12164–12175. [CrossRef] [PubMed] [Google Scholar]
  15. Nomikos M, Sanders JR, Theodoridou M, et al. Sperm-specific post-acrosomal WW-domain binding protein (PAWP) does not cause Ca2+ release in mouse oocytes. Mol Hum Reprod 2014 ; 20 : 938–947. [CrossRef] [PubMed] [Google Scholar]
  16. Ravel C, Siffroi JP. Y chromosome and spermatogenesis. Gynecol Obstet Fertil 2009 ; 37 : 901–907. [CrossRef] [PubMed] [Google Scholar]
  17. Chianese C, Fino MG, Riera Escamilla A, et al. Comprehensive investigation in patients affected by sperm macrocephaly and globozoospermia. Andrology 2015 ; 3 : 203–212. [CrossRef] [PubMed] [Google Scholar]
  18. Ravel C, Chantot-Bastaraud S, Siffroi JP, et al. Tail stump syndrome associated with chromosomal translocation in two brothers attempting intracytoplasmic sperm injection. Fertil Steril 2006 ; 86 : 719.e1-7. [CrossRef] [PubMed] [Google Scholar]
  19. De Braekeleer M, Nguyen MH, Morel F, Perrin A. Genetic aspects of monomorphic teratozoospermia: a review. J Assist Reprod Genet 2015 ; 32 : 615–623. [CrossRef] [PubMed] [Google Scholar]
  20. Escoffier J, Yassine S, Lee HC, et al. Subcellular localization of phospholipase Cζ in human sperm and its absence in DPY19L2-deficient sperm are consistent with its role in oocyte activation. Mol Hum Reprod 2015 ; 21 : 157–168. [CrossRef] [PubMed] [Google Scholar]
  21. Yassine S, Escoffier J, Martinez G, et al. Dpy19l2-deficient globozoospermic sperm display altered genome packaging and DNA damage that compromises the initiation of embryo development. Mol Hum Reprod 2015 ; 21 : 169–185. [CrossRef] [PubMed] [Google Scholar]
  22. Vanden Meerschaut F, Leybaert L, Nikiforaki D, et al. Diagnostic and prognostic value of calcium oscillatory pattern analysis for patients with ICSI fertilization failure. Hum Reprod 2013 ; 28 : 87–98. [CrossRef] [PubMed] [Google Scholar]
  23. Wolf JP, Ziyyat A, Ciapa B. ICSI et signalisation calcique. Med Sci (Paris) 2007 ; 23 : 475–477. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  24. Halet G, Marangos P, Fitzharris G, Carroll J. Ca2+ oscillations at fertilization in mammals. Biochem Soc Trans 2003 ; 31 : 907–911. [CrossRef] [PubMed] [Google Scholar]
  25. Ecker DJ, Stein P, Xu Z, et al. Long-term effects of culture of preimplantation mouse embryos on behavior. Proc Natl Acad Sci USA 2004 ; 101 : 1595–1600. [CrossRef] [Google Scholar]
  26. Fernandez-Gonzalez R, Moreira PN, Perez-Crespo M, et al. Long-term effects of mouse intracytoplasmic sperm injection with DNA-fragmented sperm on health and behavior of adult offspring. Biol Reprod 2008 ; 78 : 761–772. [CrossRef] [PubMed] [Google Scholar]
  27. Fernandez-Gonzale R, Ramirez MA, Pericuesta E, et al. Histone modifications at the blastocyst Axin1(Fu) locus mark the heritability of in vitro culture-induced epigenetic alterations in mice. Biol Reprod 2010 ; 83 : 720–727. [CrossRef] [PubMed] [Google Scholar]
  28. Tesarik J, Testart J. Treatment of sperm-injected human oocytes with Ca2+ ionophore supports the development of Ca2+ oscillations. Biol Reprod 1994 ; 51 : 385–391. [CrossRef] [PubMed] [Google Scholar]
  29. Hoshi K, Yanagida K, Yazawa H, et al. Intracytoplasmic sperm injection using immobilized or motile human spermatozoon. Fertil Steril 1995 ; 63 : 1241–1245. [PubMed] [Google Scholar]
  30. Yanagida K, Morozumi K, Katayose H, et al. Successful pregnancy after ICSI with strontium oocyte activation in low rates of fertilization. Reprod Biomed Online 2006 ; 13 : 801–806. [CrossRef] [PubMed] [Google Scholar]
  31. Kyono K, Kumagai S, Nishinaka C, et al. Birth and follow-up of babies born following ICSI using SrCl2 oocyte activation. Reprod Biomed Online 2008 ; 17 : 53–58. [CrossRef] [PubMed] [Google Scholar]
  32. Vanden Meerschaut F, Nikiforaki D, Heindryckx B, De Sutter P. Assisted oocyte activation following ICSI fertilization failure. Reprod Biomed Online 2014 ; 28 : 560–571. [CrossRef] [PubMed] [Google Scholar]
  33. Rexhaj E, Paoloni-Giacobino A, Rimoldi SF, et al. Mice generated by in vitro fertilization exhibit vascular dysfunction and shortened life span. J Clin Invest 2013 ; 123 : 5052–5060. [CrossRef] [PubMed] [Google Scholar]
  34. Yoon HJ, Bae IH, Kim HJ, et al. Analysis of clinical outcomes with respect to spermatozoan origin after artificial oocyte activation with a calcium ionophore. J Assist Reprod Genet 2013 ; 30 : 1569–1575. [CrossRef] [PubMed] [Google Scholar]
  35. Takisawa T, Doshida M, Hattori H, et al. Effect of oocyte activation by calcium ionophore A23187 or strontium chloride in patients with low fertilization rates and follow-up of babies. Hum Reprod 2011 ; 26 : P-141. [Google Scholar]
  36. Sato Y, Nakamura Y, Sakamoto E, et al. Follow up of children following new technology: TESE, IVM, and oocyte activation. Hum Reprod 2011 ; 26 : P-394. [Google Scholar]
  37. Vanden Meerschaut F, D’Haeseleer E, Gysels H, et al. Neonatal and neurodevelopmental outcome of children aged 3–10 years born following assisted oocyte activation. Reprod Biomed Online 2014 ; 28 : 54–63. [CrossRef] [PubMed] [Google Scholar]
  38. Deemeh MR, Tavalaee M, Nasr-Esfahani MH. Health of children born through artificial oocyte activation: a pilot study. Reprod Sci 2015 ; 22 : 322–328. [CrossRef] [PubMed] [Google Scholar]
  39. Ebner T, Montag M; Oocyte Activation Study Group, et al. Live birth after artificial oocyte activation using a ready-to-use ionophore: a prospective multicentre study. Reprod Biomed Monline 2015 ; 30 : 359–365. [CrossRef] [Google Scholar]
  40. Heindryckx B, Van der Elst J, De Sutter P, Dhont M. Treatment option for sperm- or oocyte-related fertilization failure: assisted oocyte activation following diagnostic heterologous ICSI. Hum Reprod 2005 ; 20 : 2237–2241. [CrossRef] [PubMed] [Google Scholar]
  41. Moaz MN, Khattab S, Foutouh IA, Mohsen EA. Chemical activation of oocytes in different types of sperm abnormalities in cases of low or failed fertilization after ICSI: a prospective pilot study. Reprod Biomed Online 2006 ; 13 : 791–794. [CrossRef] [PubMed] [Google Scholar]
  42. Heindryckx B, De Gheselle S, Gerris J, et al. Efficiency of assisted oocyte activation as a solution for failed intracytoplasmic sperm injection. Reprod Biomed Online 2008 ; 17 : 662–668. [CrossRef] [PubMed] [Google Scholar]
  43. Kyono K, Kumagai S, Nishinaka C, et al. Birth and follow-up of babies born following ICSI using SrCl2 oocyte activation. Reprod Biomed Online 2008 ; 17 : 53–58. [CrossRef] [PubMed] [Google Scholar]
  44. Borges E Jr, de Almeida Ferreira Braga DP, de Sousa Bonetti TC, et al. Artificial oocyte activation with calcium ionophore A23187 in intracytoplasmic sperm injection cycles using surgically retrieved spermatozoa. Fertil Steril 2009 ; 92 : 131–136. [CrossRef] [PubMed] [Google Scholar]
  45. Ebner T, Köster M, Shebl O, et al. Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility. Fertil Steril 2012 ; 98 : 1432–1437. [CrossRef] [PubMed] [Google Scholar]
  46. Montag M, Köster M, van der Ven K, et al. The benefit of artificial oocyte activation is dependent on the fertilization rate in a previous treatment cycle. Reprod Biomed Online 2012 ; 24 : 521–526. [CrossRef] [PubMed] [Google Scholar]
  47. Kuentz P, Vanden Meerschaut F, Elinati E, et al. Assisted oocyte activation overcomes fertilization failure in globozoospermic patients regardless of the DPY19L2 status. Hum Reprod 2013 ; 28 : 1054–1061. [CrossRef] [PubMed] [Google Scholar]
  48. Ebner T, Oppelt P, Wöber M, et al. Treatment with Ca2+ ionophore improves embryo development and outcome in cases with previous developmental problems: a prospective multicenter study. Hum Reprod 2015 ; 30 : 97–102. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.